NP89
NOTICE OF ACCEPTANCE OF PARTIAL SEC. 8 & 9 EMAILED
10/11/2025
Voltar para busca
Dado oficial do USPTO
NEURIMMUNE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
NEURIMMUNE
ST13
US500000085683759Classe
1, 5, 42, 44
Pedido
85683759
Registro
4788066
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
103
Atualização mais recente
02/12/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42, 44
Data de depósito
22/07/2012
Data de registro
11/08/2015
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/11/2025
Última transação
02/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
99
Localização do titular
Schlieren, CH
Examinador
LEHKER,DAWN FELDMAN
Titulares e representantes
Titulares
Neurimmune Holding AG
Representantes
Janice Housey Litmus Law PLLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Active chemical ingredients for use in the manufacture of pharmaceuticals for treating diseases of the CNSmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfectionsimmunologic diseasesinflammatory diseasesrespiratory diseasespsychological diseases; industrial chemicals; chemical preparations for scientific purposesother than for medical or veterinary purposes; chemical preparations for use in photography; biological preparations for use in cell cultures other than for medical or veterinary purposes; biomedical compoundspeptide substrates used in analyzing and detecting certain toxins for laboratory or research use; Biochemicalssynthetic polypeptides made from amino acids that do not derive from animals for use in diagnostic and therapeutic agents
Classe 5
Pharmaceutical preparations to treat diseases of the nervous systeminfectious diseasesneoplasmsdiseases of the immune systemendocrine and metabolic diseasesdiseases of the circulatory systemdiseases of the eye; veterinary preparations to treat diseases of the nervous systeminfectious diseasesneoplasmsdiseases of the immune systemendocrine and metabolic diseasesdiseases of the circulatory systemdiseases of the eye; pharmaceutical preparations for immunotherapy; pharmaceutical preparations for use as tumor suppressing agents; pharmaceutical preparations to treat neurodegenerative diseases; pharmaceutical preparations for use in immunogenics; vaccines; diagnostic kits consisting primarily of monoclonal antibodiesbuffers and reagents for use in disease testing; biological preparations in the nature of antibodies targeting specific epitopes of proteins for use in the treatment of diseases of the CNSmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfectionsimmunologic diseasesinflammatory diseasesrespiratory diseasespsychological diseases; synthetic peptides for use in the treatment of diseases of the CNSmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfections; biological preparations for the treatment of diseases of the CNSmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfections; sanitary preparations for medical use; biocides; diagnostic preparations for medical and veterinary use; sanitary towels; dietetic foodgluten-free foodlow-sodium foodlow-calorie or reduced calorie food for weight reduction adapted for medical purposesdietetic bread and dietetic noodles; dietetic beveragesgluten-free beverageslow-sodium beveragesdietetic tea; low calorie or reduced-calorie beverages for weight reduction adapted for medical purposeslow calorie or reduced calorie fruit beverages: protein antibodies sold as an ingredient of pharmaceuticals for the treatment of diseases of the CNSmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfectionsimmunologic diseasesinflammatory diseasesrespiratory diseasespsychological diseases
Classe 42
Testinginspection or research of pharmaceuticalscosmetics or foodstuffs; consultation and providing information about testinginspection or research of pharmaceuticalscosmetics or foodstuffs ; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research in the field of biotechnology and antibodies; providing scientific information of testinginspection or research of medical treatment and technique; scientific research about health care; biology research ; computer software designcomputer programmingmaintenance of computer software; computer hardware design and development; computer software design and development
Classe 44
Medical services; medical services in the field of immunity; providing medical information; physical examination for medical purposes; preparation and dispensing of medications; dietary and nutritional guidance; consultancy and providing information of health care; veterinary services; beauty salons; animal grooming; health care; Providing information relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals
Publicações
Histórico de despachos e eventos da marca no USPTO.
103 publicações encontradas
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/11/2025
9G8P
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
10/11/2025
8PRT
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
10/11/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/11/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
24/07/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
19/05/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
19/05/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
19/05/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/05/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/05/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/05/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/05/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/05/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/05/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
11/08/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/11/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/11/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/11/2023
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
03/06/2022
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
03/06/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
26/05/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
21/01/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
21/01/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
21/01/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21/01/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
21/01/2022
ES8R
TEAS SECTION 8 RECEIVED
16/12/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
21/07/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
21/07/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
21/07/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21/07/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/08/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/03/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
11/08/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26/05/2015
PUBO
PUBLISHED FOR OPPOSITION
26/05/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/05/2015
RPUB
NOA CANCELLED; REPUBLICATION REQUIRED
19/04/2015
IUCN
NOTICE OF ALLOWANCE CANCELLED
19/04/2015
ATRQ
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
03/04/2015
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
02/04/2015
APET
ASSIGNED TO PETITION STAFF
02/04/2015
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
26/03/2015
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
13/12/2014
EX1G
SOU EXTENSION 1 GRANTED
11/12/2014
EXT1
SOU EXTENSION 1 FILED
11/12/2014
EEXT
SOU TEAS EXTENSION RECEIVED
11/12/2014
CRTP
REG. CANCELLED - RESTORED TO PENDENCY
25/08/2014
APET
ASSIGNED TO PETITION STAFF
20/08/2014
RCII
REQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED
20/08/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
19/08/2014
CHPB
POST PUBLICATION AMENDMENT - ENTERED
16/07/2014
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
16/07/2014
IUCN
NOTICE OF ALLOWANCE CANCELLED
16/07/2014
APET
ASSIGNED TO PETITION STAFF
09/07/2014
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
24/06/2014
PPAR
POST PUBLICATION AMENDMENT RECEIVED
14/05/2014
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
14/05/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
29/04/2014
PUBO
PUBLISHED FOR OPPOSITION
29/04/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/04/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
27/03/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/03/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/03/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/03/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/03/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/02/2014
GNRT
NON-FINAL ACTION E-MAILED
05/02/2014
CNRT
NON-FINAL ACTION WRITTEN
05/02/2014
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
05/02/2014
OTHE
CASE RETURNED TO EXAMINATION
04/02/2014
IUCN
NOTICE OF ALLOWANCE CANCELLED
04/02/2014
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
17/12/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22/10/2013
PUBO
PUBLISHED FOR OPPOSITION
22/10/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/10/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
18/09/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/09/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/09/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/09/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/09/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
22/03/2013
GNRT
NON-FINAL ACTION E-MAILED
22/03/2013
CNRT
NON-FINAL ACTION WRITTEN
22/03/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/03/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/03/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/03/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
28/02/2013
GNRT
NON-FINAL ACTION E-MAILED
28/02/2013
CNRT
NON-FINAL ACTION WRITTEN
28/02/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/02/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/02/2013
ALIE
ASSIGNED TO LIE
05/02/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/02/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/10/2012
GNRT
NON-FINAL ACTION E-MAILED
09/10/2012
CNRT
NON-FINAL ACTION WRITTEN
09/10/2012
DOCK
ASSIGNED TO EXAMINER
05/10/2012
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
13/08/2012
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
13/08/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
27/07/2012
NWAP
NEW APPLICATION ENTERED
25/07/2012
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NEURIMMUNE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.